بدائل البحث:
latent decrease » latency decreased (توسيع البحث), largest decrease (توسيع البحث), content decreased (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
a latent » _ latent (توسيع البحث), _ patent (توسيع البحث)
b marked » _ marked (توسيع البحث), a marked (توسيع البحث), n marked (توسيع البحث)
latent decrease » latency decreased (توسيع البحث), largest decrease (توسيع البحث), content decreased (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
a latent » _ latent (توسيع البحث), _ patent (توسيع البحث)
b marked » _ marked (توسيع البحث), a marked (توسيع البحث), n marked (توسيع البحث)
-
1
-
2
-
3
-
4
-
5
-
6
Posterior distribution of the effect of the latent variable on the probability of seeking traditional remedies after a potential dog bite indicates a decreased likelihood of individuals seeking traditional remedies.
منشور في 2025"…<p>Posterior distribution of the effect of the latent variable on the probability of seeking traditional remedies after a potential dog bite indicates a decreased likelihood of individuals seeking traditional remedies.…"
-
7
-
8
Raw data of the charts in Fig 5.
منشور في 2024"…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …"
-
9
Antibodies used in western blot analysis.
منشور في 2024"…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …"
-
10
Raw data of the charts in Fig 3.
منشور في 2024"…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …"
-
11
Raw data of the charts in Fig 1.
منشور في 2024"…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …"
-
12
Raw data of the charts in Fig 6.
منشور في 2024"…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …"
-
13
Raw data of the charts in Fig 2.
منشور في 2024"…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …"
-
14
-
15
-
16
<b>Effect of Marked Weight Loss on Adipose Tissue Biology in People with Obesity and Type 2 Diabetes</b>
منشور في 2025"…</p><p dir="ltr"><b>Results: </b>Weight loss: <a href="" target="_blank">i) </a><a href="" target="_blank">decreased adipose tissue </a>expression of genes related to extracellular matrix remodeling; ii) decreased adipose tissue expression of SERPINE 1 which encodes plasminogen activator inhibitor-1 (PAI-1); iii) did not decrease adipose tissue immune cell content or expression of genes involved in inflammation; iv) decreased adipose tissue ceramide content; v) decreased plasma <a href="" target="_blank">PAI-1 </a>and leptin concentrations and increased plasma high-molecular weight (HMW) adiponectin; and vi) decreased plasma small extracellular vesicle (sEV) concentration and the sEV content of microRNAs proposed to inhibit insulin action, and completely reversed the inhibitory effect of plasma sEVs on insulin signaling in myotubes.…"
-
17
-
18
-
19
-
20